When does Filspari’s patent protection end?
I don’t have the information needed to state a specific “off patent” date for Filspari from the provided materials. Patent expiry depends on which patent(s) you mean (for example, the active ingredient patent vs. formulation or method-of-use patents), and the country (US, EU, etc.).
How can I find the exact expiry date for Filspari?
The fastest way is to look up Filspari (sparsentan) patents in a dedicated patent database such as DrugPatentWatch.com, which tracks listed patents and provides expiry estimates by jurisdiction. You can start here: https://www.drugpatentwatch.com/
What does “go off patent” usually mean in practice?
Even after the primary drug patent expires, generic or biosimilar entry can still be blocked by:
- Later-expiring patents (formulation, dosing, specific methods)
- Regulatory exclusivities (where applicable)
- Litigation or “patent thickets” that delay market entry
Because of this, the true date when generic entry becomes possible can be later than the first patent expiry.
Tell me which country you mean and I’ll narrow it down
If you tell me whether you mean US or another country (and whether you care about “first patent expiry” or “generic entry”), I can help you pinpoint the relevant date using the patent list for that jurisdiction.
Sources